Health Care & Life Sciences » Pharmaceuticals | Assembly Biosciences Inc.

Assembly Biosciences Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
9,018.80
14,804
Cost of Goods Sold (COGS) incl. D&A
6.20
11.00
65.00
80.30
-
-
Gross Income
6.20
11.00
65.00
80.30
-
-
SG&A Expense
19,598.60
23,945.50
29,590.60
45,198.20
61,026.40
106,896
EBIT
19,604.80
23,956.50
29,655.60
45,278.50
52,226.90
92,735
Non Operating Income/Expense
-
-
27.00
399.20
615.10
-
Pretax Income
19,403.80
23,788.80
28,453.80
44,879.20
51,858.80
89,652
Income Tax
-
-
-
617.70
9,050.20
1,099
Consolidated Net Income
19,403.80
23,788.80
28,453.80
44,261.60
42,808.50
90,751
Net Income
19,403.80
23,788.80
28,453.80
44,261.60
42,808.50
90,751
Net Income After Extraordinaries
19,403.80
23,788.80
28,453.80
44,261.60
42,808.50
90,751
Net Income Available to Common
19,403.80
23,788.80
28,453.80
44,261.60
42,808.50
90,751
EPS (Basic)
5.00
3.40
1.81
2.57
2.41
3.98
Basic Shares Outstanding
3,878.70
6,998.90
15,702.60
17,226.20
17,750.40
22,801.60
EPS (Diluted)
5.00
3.40
1.81
2.57
2.41
3.98
Diluted Shares Outstanding
3,878.70
6,998.90
15,702.60
17,226.20
17,750.40
22,801.60
EBITDA
19,598.60
23,945.50
29,590.60
45,198.20
52,007.70
92,092
Non-Operating Interest Income
201.00
167.70
1,228.80
-
983.20
3,083

About Assembly Biosciences

View Profile
Address
11711 North Meridian Street
Carmel Indiana 46032
United States
Employees -
Website http://www.assemblybio.com
Updated 07/08/2019
Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin on October 7, 2005 and is headquartered in Carmel, IN.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.